Zobrazeno 1 - 10
of 238
pro vyhledávání: '"RC254-282"'
Autor:
Gyungyub Gong, Min Jeong Song, Kyung-Ja Cho, Ji-Seon Jeong, Yong Mee Cho, Uiree Jo, Joon Seon Song
Publikováno v:
Cancer Medicine, Vol 10, Iss 24, Pp 8899-8908 (2021)
Cancer Medicine
Cancer Medicine
Introduction A pericardial effusion (PE) has a variable etiology and the primary role is diagnosis of metastatic malignancy. We analyzed the PE cytology in a large cohort in accordance with the international system for reporting serous fluid cytopath
Publikováno v:
Cancer Cell International, Vol 21, Iss 1, Pp 1-14 (2021)
Cancer Cell International
Cancer Cell International
Background Human papillomavirus (HPV) E6/E7 mRNA in situ hybridization (HPV E6/E7 RNAscope) appears to be a sensitive and specific technique in detecting transcriptionally active HPV. We aimed to examine the diagnostic utility of this technique in en
Autor:
Guzhalinuer Abulizi, Gulixian Tuerxun, Tangnuer Abulimiti, Gulimire Naizhaer, Ling Lu, Yuan-Yuan Zhang, Hua Li, Guzhanuer Abuduxikuer, Patiman Mijiti, Anaerguli Maimaiti, Guligeina Abudurexiti, Kailibinuer Aierken
Publikováno v:
Cancer Medicine
Cancer Medicine, Vol 10, Iss 24, Pp 9022-9029 (2021)
Cancer Medicine, Vol 10, Iss 24, Pp 9022-9029 (2021)
Background The careHPV test as a primary screening method for cervical cancer has been proven to be the best option for Uyghur women in Xinjiang in a previous study. In this research, we aim to discuss the appropriate age for Uyghur women in Xinjiang
Autor:
Toru Matsunaga, Eiichiro Hirakawa, Shingo Kamoshida, Emi Ibuki, Kaori Enomoto, Akihiro Nakamura, Tadashi Sofue, Reiji Haba, Hiroyuki Ohsaki
Publikováno v:
Cancer Medicine
Cancer Medicine, Vol 10, Iss 24, Pp 8846-8853 (2021)
Cancer Medicine, Vol 10, Iss 24, Pp 8846-8853 (2021)
Background p53 immunostaining is routinely used as a surrogate marker for TP53 mutational status. In urine cytology, p53 immunocytochemistry is reportedly useful in detecting urothelial carcinoma cells as well as in improving the detection sensitivit
Autor:
Sara Bass, Kim R. Geisinger, Dianne Grunes, Carolann Risley, Megan A. Clarke, Sarah Wagner, Lei Zhang, Rhonda M. Rives, Ashish Jannela, Mark Schiffman, Krishna K. Ayyalasomayajula, Jody C. Morgan, Joseph Boland, Kenyata J. Owens, Laree Hiser, Nicolas Wentzensen, Mary W. Stewart
Publikováno v:
Cancer Medicine
Cancer Medicine, Vol 10, Iss 23, Pp 8641-8650 (2021)
Cancer Medicine, Vol 10, Iss 23, Pp 8641-8650 (2021)
Background Mississippi (MS) has among the highest rates of cervical cancer incidence and mortality in the United States, with disproportionately higher rates among Blacks compared to Whites. Here, we evaluate the prevalence of high‐risk human papil
Publikováno v:
Cancer Cell International, Vol 21, Iss 1, Pp 1-12 (2021)
Background High-dose melphalan (HDMEL, 200 mg/m2) is considered as the standard conditioning regimen for autologous hematopoietic stem cell transplantation (auto-HSCT) in multiple myeloma (MM). However, whether the combination of melphalan with busul
Publikováno v:
Cancer Cell International, Vol 21, Iss 1, Pp 1-10 (2021)
Cancer Cell International
Cancer Cell International
Background Controversial findings have been reported in the impact of speckle-type POZ protein (SPOP) on clinicopathological features and prognosis in diverse cancers. We conducted this meta-analysis to confirm whether SPOP was an effective biomarker
Publikováno v:
Cancer Cell International, Vol 21, Iss 1, Pp 1-19 (2021)
Cancer Cell International
Cancer Cell International
Background The prognosis of high grade serous ovarian cancer (HGSOC) patients is closely related to the immune microenvironment and immune response. Based on this, the purpose of this study was to construct a model to predict chemosensitivity and pro
Publikováno v:
Cancer Cell International, Vol 21, Iss 1, Pp 1-11 (2021)
Cancer Cell International
Cancer Cell International
Background Ferroptosis is a recently recognised new type of cell death which may be a potential target for cancer therapy. In the present study, we aimed to screen ferroptosis-related differentially expressed long non-coding RNAs as biomarkers to pre
Publikováno v:
Cancer Cell International, Vol 21, Iss 1, Pp 1-17 (2021)
Cancer Cell International
Cancer Cell International
Background Most previous studies compared the risk for non-melanoma skin cancer (NMSC) in biologic-treated common inflammatory diseases with the general population. Whether the increased NMSC risk is caused by the disease itself, the biologics, or bo